期刊文献+

口服抗凝剂的妇科手术患者围手术期管理 被引量:6

Perioperative Management in Gynecological Patients Receiving Oral Anticoagulation Therapy
下载PDF
导出
摘要 口服抗凝剂可造成妇女的月经量增多及凝血系统发生改变,加之妇科患者及妇科手术独有的特点,妇科手术患者围手术期抗凝管理是个重要的临床难题。口服抗凝剂的患者如进行手术,将面临着出血及血栓形成的风险,医生既要考虑手术前后可能出现的出血情况,又要避免因暂时停用抗凝药物而发生血栓栓塞的危险,此类患者手术成功的关键是抗凝剂的使用情况及手术时间的选择。因此,妇科手术患者的术前评估及术中、术后管理具有重要的临床意义。综述低分子肝素作为桥梁的围手术抗凝方法在妇科临床工作中的应用。 Oral anticoagulation medicine may cause women with heavy menstrual bleeding and changing their blood system,and with the characteristics of gynecology and gynecological surgery,it is a difficult clinical problem in gynecological surgery.When there is an operation,the doctor should balance individual risk for thromboembolism and bleeding. How to use anticoagulator and to select proper time is crucial to successful. Therefore,it is important and clinical significance in preoperative evaluation and perioperative management in gynecological surgery. This article discussed the application of the anticoagulant therapy in the gynecological clinical treatment.
作者 孙娟 史惠蓉
出处 《国际妇产科学杂志》 CAS 2011年第4期354-357,共4页 Journal of International Obstetrics and Gynecology
关键词 抗凝药 肝素 低分子量 围手术期医护 妇科外科手术 手术后并发症 Anticoagulants Heparin low-molecular-weight Perioperative care Gynecological surgical procedures Postoperative complication
  • 相关文献

参考文献27

  • 1Faltas B,Kouides PA.Update on perioperative bridging in patients on chronic oral anticoagulation [J]. Expert Rev Cardiovase Ther, 2009,7 (12) : 1533-1539.
  • 2Levy JH, Key NS ,Azran MS ,et al.Novel oral anticoagulants :impli- cations in the perioperative setting ~Jl. Anesthesiology,2010,113 (3) :726-745.
  • 3Spyropoulos AC,Bauersachs RM,Omran H,et al.Periprocedural bridging therapy in patients receiving chronic oral anticoagulation therapy [J ]. Curr Med Res Opin ,2006,22(9) : 1109-1122.
  • 4Lee SO, Li M J, Ho HM, et al.Perioperative transient ischemic attack caused by the cessation of warfarin [J ]. Acta Anaesthesiol Taiwan, 2010,48(4) : 188-190.
  • 5Varkarakis IM ,Rais-Bahrami S ,Allaf ME. Laparoscopic renal- adrenal surgery in patients on oral anticoagulant therapy [J]. J Urol, 2005,174(3 ) : 1020-1023.
  • 6Catheline JM,Capelluto E,Gaillard JL,et al. Thromboembolism prophylaxis and incidence of thromboembolic complications after laparoscopic surgery [ J ]. Int J Surg Investig, 2000,2 ( 1 ) : 41447.
  • 7Angelo M, Stockner I, Wiedermann CJ,et al. Bleeding risk and perioperative management of patients anticoagulated with vitamin K antagnosists [ J ]. Wien Med Wochenschr, 2008,158 (21 ) : 615-620.
  • 8Lyman GH,Khorana AA,Falanga A,et al. American society of clinical oncology guideline:recommendations for venous throm- boembolism prophylaxis and treatment in patients with eancer[J ]. J Clin Oneol, 2007,25 (34) : 5490-5505.
  • 9Duska LR, Garrett L, Henretta M. When 'never-events' occur despite adherence to clinical guidelines : The case of venous throm- boembolism in clear cell cancer of the ovary compared with other epithelial histologic subtypes [J]. Gynecol Oncol,2010,116 (3) : 374-377.
  • 10Chew HK,Wun T,Harvey D,et al. Incidence of venous throm- boembolism and its effect on survival among patients with common cancers [J ]. Arch Intern Med, 2006,166 (4) : 458-464.

二级参考文献9

  • 1Pifarre R. Thrombosis and cardiovascular disease. Mde Clin North Am, 1998, 82 (3): 511-522.
  • 2Aagaard J, Tingkff J, Hansen CN, et al. Twelve years clinical experience with the Carbomedics prosthetic heart valve. J Heart Valve Dis, 2001, 3:10 (2) :177- 184.
  • 3Xin-Min Zhou, Wei Zhuang, Jian-Guo Hu, et al. LowDose Anticoagulation in Chinese Patients with Mechanical Heart Valves. Asian Cardiovasc Thorae Ann, 2005, 13:341-344.
  • 4Eckman MH, Beshansky JR, Durand-Zaleski I, et al. Anticoagulation for noncardiac procedures in patients with prosthetic heart valves. JAMA, 1990, 263 : 1513- 1521.
  • 5Kirtane AJ, Rahram AM, Martinezclark P, et al. Adherence to American College of Cardiology/American Heart Association Guidelines for the management of anticoagulation in patients with mechanical valves undergoing elective outpatient procedures. Am J Cardiol, 2006, 97(6) :891-893.
  • 6Prendergast BD. Management of patients with prosthetic heart valves during non-cardiac surgery. Przegl Lek, 2004, 61(6) :556-559.
  • 7Garcia DA, Regan S, Henault LE, et al. Risk of thromboembolism with short-term intqrruption of warfarin therapy. Arch Intern Med, 2008, 168(1 ) :63-69.
  • 8Spyropoulos AC, Turpie AG, Dunn AS, et al. Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants., the REGIMEN registry. J Thromb Haemost, 2006, 4(6):1246-1252.
  • 9Goneppanavar Umesh, Swati Verma and Kaur Jasvinder, et al. Anesthetic management of a patient with prosthetic heart valve for non-cardiac surgery: A ease report. Cases Journal, 2008, 1: 196.

共引文献5

同被引文献29

引证文献6

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部